Allbirds (NASDAQ:BIRD – Get Free Report) had its target price cut by Morgan Stanley from $12.00 to $8.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 22.70% from the company’s previous close.
Allbirds Stock Performance
Shares of BIRD opened at $6.52 on Tuesday. The stock has a market capitalization of $51.70 million, a P/E ratio of -0.41 and a beta of 1.61. The company’s fifty day moving average is $7.44 and its two-hundred day moving average is $10.30. Allbirds has a 1 year low of $6.11 and a 1 year high of $22.40.
Allbirds (NASDAQ:BIRD – Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($2.68) earnings per share for the quarter, topping analysts’ consensus estimates of ($3.13) by $0.45. Allbirds had a negative net margin of 60.43% and a negative return on equity of 65.30%. The business had revenue of $43.00 million for the quarter, compared to analysts’ expectations of $42.11 million. During the same period in the prior year, the company posted ($4.20) EPS. Sell-side analysts predict that Allbirds will post -11.89 EPS for the current year.
Institutional Inflows and Outflows
Allbirds Company Profile
Allbirds, Inc manufactures and sells footwear and apparel products for men and women in the United States and internationally. The company offers a range of lifestyle and performance shoes; and apparel, including classic tees and sweats, socks, and underwear. It sells its products through its retail stores, as well as online.
Featured Stories
- Five stocks we like better than Allbirds
- Are Penny Stocks a Good Fit for Your Portfolio?
- Oracle Announces Game-Changing News for the AI Industry
- The Role Economic Reports Play in a Successful Investment Strategy
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Allbirds Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allbirds and related companies with MarketBeat.com's FREE daily email newsletter.